Effects of Abatacept in Patients With Early Rheumatoid Arthritis
NCT02504268 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 994
Last updated 2021-06-28
Summary
The purpose of this study is to determine if abatacept is effective in the treatment of early rheumatoid arthritis.
Conditions
Interventions
- DRUG
- DRUG
-
Methotrexate
- OTHER
-
Abatacept Placebo
- OTHER
-
Methotrexate Placebo
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol Myers Squibb · Bristol-Myers Squibb
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-03
- Primary Completion
- 2017-01-16
- Completion
- 2020-03-19
Countries
- United States
- Argentina
- Australia
- Austria
- Brazil
- Canada
- Chile
- Colombia
- Czechia
- Finland
- France
- Germany
- Hungary
- Israel
- Italy
- Japan
- Mexico
- Monaco
- Netherlands
- Peru
- Poland
- Qatar
- Romania
- Russia
- Singapore
- South Africa
- South Korea
- Spain
- Sweden
- Taiwan
- United Kingdom
Study Locations
More Related Trials
-
Abatacept With Methotrexate- Phase IIB
NCT00162266 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate
NCT04909801 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate
NCT00345748 ·Status: COMPLETED ·Phase: PHASE2
-
Phase IIIB Subcutaneous Abatacept Monotherapy Study
NCT00547521 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients
NCT01001832 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate
NCT02629159 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis
NCT02557100 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)
NCT00254293 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
NCT02722694 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy
NCT00124982 ·Status: COMPLETED ·Phase: PHASE3
-
Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis
NCT00095147 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy
NCT01960855 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid Arthritis
NCT00484289 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Intravenous ACZ885 and Oral Methotrexate Therapy in Patients With Early Rheumatoid Arthritis
NCT00487825 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone
NCT02066389 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)
NCT02706951 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken Methotrexate
NCT02706873 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients
NCT00124449 ·Status: COMPLETED ·Phase: PHASE2
-
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
NCT02037737 ·Status: COMPLETED
-
Abatacept Post-marketing Clinical Study in Japan
NCT01758198 ·Status: COMPLETED ·Phase: PHASE4
-
Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis
NCT00291915 ·Status: UNKNOWN ·Phase: PHASE4
-
ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background Methotrexate
NCT02387762 ·Status: COMPLETED ·Phase: PHASE2
-
Methotrexate-Inadequate Response Study
NCT00559585 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis
NCT00299130 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis
NCT00299104 ·Status: COMPLETED ·Phase: PHASE3